Avadel Pharmaceuticals PLC
AVDLDelisted Feb 12, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001012477
Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Avadel Pharmaceuticals PLC as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 156
- +30 vs. Q1 2024
- Shares held
- 74.0M
- +4.44M (+6.4%) vs. Q1 2024
- Total value
- $1.04B
- −$136.2M (−11.6%) vs. Q1 2024
- New holders
- 50
- 46 more added
- Sold out
- 20
- 36 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVDL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $16 |
| Q1 2026 | 2 | $442 |
| Q4 2025 | 208 | $1.60B |
| Q3 2025 | 188 | $1.22B |
| Q2 2025 | 174 | $721.2M |
| Q1 2025 | 177 | $613.0M |
| Q4 2024 | 160 | $837.4M |
| Q3 2024 | 176 | $979.2M |
| Q2 2024 | 156 | $1.04B |
| Q1 2024 | 126 | $1.18B |
| Q4 2023 | 113 | $795.3M |
| Q3 2023 | 99 | $559.4M |
| Q2 2023 | 101 | $856.2M |
| Q1 2023 | 93 | $443.2M |
| Q4 2022 | 83 | $239.5M |
| Q3 2022 | 76 | $157.2M |
| Q2 2022 | 82 | $82.3M |
| Q1 2022 | 81 | $244.5M |
| Q4 2021 | 85 | $287.0M |
| Q3 2021 | 82 | $314.2M |
| Q2 2021 | 80 | $219.1M |
| Q1 2021 | 77 | $294.4M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Avadel Pharmaceuticals PLC; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cetera Investment Advisers | 107,787 | $1.52M | 0.00% | −6,191−5.4% | Reduced |
| JPMorgan Chase & Co | 112,766 | $1.59M | 0.00% | +59,545+111.9% | Added |
| Iridian Asset Management LLC | 117,700 | $1.65M | 0.37% | +45,675+63.4% | Added |
| MML Investors Services, LLC | 119,856 | $1.69M | 0.01% | +17,925+17.6% | Added |
| Rhumbline Advisers | 122,675 | $1.72M | 0.00% | +121,130+7,840.1% | Added |
| Dorsey Wright & Associates | 125,905 | $1.77M | 0.46% | −1,735−1.4% | Reduced |
| Schulhoff & Co Inc | 137,000 | $1.93M | 0.87% | 00.0% | Unchanged |
| Troluce Capital Advisors LLC | 150,000 | $2.11M | 0.44% | +150,000 | New |
| J. Goldman & Co LP | 174,952 | $2.46M | 0.09% | +174,952 | New |
| Obermeyer Wood Investment Counsel, LLLP | 204,105 | $2.87M | 0.16% | −75,389−27.0% | Reduced |
| Exome Asset Management LLC | 209,092 | $2.94M | 2.62% | +209,092 | New |
| National Philanthropic Trust | 219,296 | $3.08M | 0.06% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 220,701 | $3.10M | 0.00% | +220,701 | New |
| UBS Group AG | 234,342 | $3.29M | 0.00% | +220,812+1,632.0% | Added |
| Nuveen Asset Management, LLC | 250,689 | $3.52M | 0.00% | +250,689 | New |
| Barclays PLC | 269,261 | $3.79M | 0.00% | +269,261 | New |
| Balyasny Asset Management LLC | 284,299 | $4.00M | 0.01% | −25,413−8.2% | Reduced |
| Ameriprise Financial Inc | 300,940 | $4.23M | 0.00% | +9,666+3.3% | Added |
| Bank of New York Mellon Corp | 325,388 | $4.57M | 0.00% | +325,388 | New |
| Knott David M Jr | 333,000 | $4.68M | 1.87% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 350,000 | $4.92M | 0.49% | +350,000 | New |
| Parkman Healthcare Partners LLC | 378,289 | $5.32M | 0.72% | −9,481−2.4% | Reduced |
| Lord, Abbett & Co. LLC | 394,834 | $5.55M | 0.02% | +201,601+104.3% | Added |
| Ally Bridge Group (NY) LLC | 430,245 | $6.05M | 3.60% | −116,791−21.3% | Reduced |
| Driehaus Capital Management LLC | 470,341 | $6.61M | 0.06% | −5,096−1.1% | Reduced |
| Soleus Capital Management, L.P. | 509,000 | $7.16M | 0.63% | +509,000 | New |
| Hudson Bay Capital Management LP | 522,277 | $7.34M | 0.06% | +273,117+109.6% | Added |
| Knoll Capital Management, LLC | 600,000 | $8.44M | 5.68% | 00.0% | Unchanged |
| Modera Wealth Management, LLC | 602,608 | $8.47M | 0.12% | +2,159+0.4% | Added |
| Deutsche Bank AG | 604,135 | $8.49M | 0.00% | +39,135+6.9% | Added |
| Altium Capital Management LP | 610,000 | $8.58M | 3.54% | +56,943+10.3% | Added |
| Kennedy Capital Management, Inc. | 654,116 | $9.20M | 0.20% | +969+0.1% | Added |
| Bank of America Corp | 692,359 | $9.73M | 0.00% | +656,884+1,851.7% | Added |
| Cutter Capital Management, LP | 733,001 | $10.3M | 3.14% | +191,075+35.3% | Added |
| MPM Oncology Impact Management LP | 783,242 | $11.0M | 1.71% | −87,907−10.1% | Reduced |
| Morgan Stanley | 833,312 | $11.7M | 0.00% | +167,901+25.2% | Added |
| Samsara BioCapital, LLC | 967,527 | $13.6M | 2.85% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 994,738 | $14.0M | 0.03% | −916,245−47.9% | Reduced |
| Checkpoint Capital L.P. | 1,138,178 | $16.0M | 9.65% | +436,791+62.3% | Added |
| State Street Corp | 1,139,515 | $16.0M | 0.00% | +1,102,671+2,992.8% | Added |
| Geode Capital Management, LLC | 1,160,820 | $16.3M | 0.00% | +1,056,593+1,013.7% | Added |
| Tri Locum Partners LP | 1,189,518 | $16.7M | 4.23% | +70.0% | Added |
| Tang Capital Management LLC | 1,230,000 | $17.3M | 1.76% | +182,725+17.4% | Added |
| Brandes Investment Partners, LP | 1,483,439 | $20.9M | 0.26% | +21,214+1.5% | Added |
| Woodline Partners LP | 1,504,532 | $21.2M | 0.20% | +4,008+0.3% | Added |
| Two Seas Capital LP | 2,115,279 | $29.7M | 4.85% | +1,797,039+564.7% | Added |
| Citadel Advisors LLC | 2,241,281 | $31.5M | 0.03% | +677,391+43.3% | Added |
| Wealth Effects LLC | 2,267,855 | $31.9M | 11.56% | +3,629+0.2% | Added |
| Braidwell LP | 2,898,639 | $40.8M | 1.28% | +230,090+8.6% | Added |
| Vanguard Group Inc | 3,691,363 | $51.9M | 0.00% | +3,691,363 | New |
| Vivo Capital, LLC | 3,972,099 | $55.8M | 5.16% | 00.0% | Unchanged |
| BlackRock Inc. | 4,816,743 | $67.7M | 0.00% | +4,740,301+6,201.2% | Added |
| Gendell Jeffrey L | 5,740,143 | $80.7M | 2.82% | +32,025+0.6% | Added |
| Polar Capital Holdings Plc | 6,560,415 | $92.2M | 0.54% | −193,257−2.9% | Reduced |
| Janus Henderson Group PLC | 13,297,317 | $187.1M | 0.10% | +382,157+3.0% | Added |
| Alliancebernstein L.P. | 101,224 | – | – | +101,224 | New |
| RTW Investments, LP | 0 | $0 | 0.00% | −8,798,558−100.0% | Sold out |
| Penn Capital Management Co Inc | 0 | $0 | 0.00% | −686,606−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −383,641−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −374,203−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −223,660−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −168,528−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −69,700−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −62,609−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −58,934−100.0% | Sold out |
| Edge Wealth Management LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −21,749−100.0% | Sold out |
| Blue Zone Wealth Advisors, LLC | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Buckingham Strategic Wealth, LLC | 0 | $0 | 0.00% | −13,710−100.0% | Sold out |
| Wrapmanager Inc | 0 | $0 | 0.00% | −10,637−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −4,469−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Hantz Financial Services, Inc. | 0 | $0 | 0.00% | −785−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −455−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −19−100.0% | Sold out |